
Healthy babies born in UK using DNA from three people
It's an innovation made possible by a 2016 change in British law. Though banned in the United States and many other countries, the technique is also permitted in Australia.
The news 'marks an important milestone,' said Dr. Zev Williams, who directs the Columbia University Fertility Centre but was not involved in the work.
'Expanding the range of reproductive options will empower more couples to pursue safe and healthy pregnancies'.
Why mitochondrial diseases are so dangerous
Most of our DNA comes from the nucleus of a cell, inherited from both mother and father. But there's also some DNA outside of the cell's nucleus, in structures called mitochondria - tiny energy-producing structures that come only from the mother.
When mitochondrial DNA carries dangerous mutations, it can lead to severe and often untreatable conditions in children, from seizures and muscle weakness to organ failure and early death.
Screening embryos during IVF can sometimes detect these mutations - but not always. As a result of these rare and uncertain cases, scientists have been developing a pioneering workaround: replacing the mutated mitochondria with healthy ones from a donor egg.
The mother's genetic material is extracted and inserted into a donor egg that has had its own nucleus removed, keeping the donor's mitochondria intact but none of her traits. The resulting embryo contains DNA from three people: the mother, the father, and a third-party mitochondrial donor.
Outcomes and early results from the UK study
Researchers from Newcastle University in the UK and Monash University in Australia, writing in the New England Journal of Medicine, reported that they applied the technique to embryos from 22 women. Eight healthy babies have been born so far, and one woman remains pregnant.
One of the babies showed slightly elevated levels of abnormal mitochondria - but not high enough to cause disease, experts say. Still, doctors will continue to monitor development.
Dr. Andy Greenfield, a reproductive health expert at the University of Oxford, called the work 'a triumph of scientific innovation,' and said the method of exchanging mitochondria would only be used for a small number of women for whom other ways of avoiding passing on genetic diseases, like testing embryos at an early stage, was not effective.
While the term 'three-parent baby' makes headlines, the amount of donor DNA involved is tiny - less than 1 per cent of the child's genome.
"If you had a bone marrow transplant from a donor... you will have much more DNA from another person,' noted stem cell expert Robin Lovell-Badge.
So far, 35 families in the UK have been approved to use the technique, which is closely regulated.
Critics have voiced concerns over the long-term effects of heritable genetic changes, which is partly why the US currently prohibits clinical research into such methods. Federal restrictions have blocked the FDA from even considering applications involving embryos altered in this way
But for families like Liz Curtis', the technique offers something they never had before: hope. Her daughter Lily died of a mitochondrial disease in 2006 at just eight months old.
She said the diagnosis 'turned our world upside down, and yet nobody could tell us very much about it, what it was or how it was going to affect Lily.'
Curtis later founded the Lily Foundation in her daughter's name to raise awareness and support research into the disease, including the latest work done at Newcastle University.
'It's super exciting for families that don't have much hope in their lives,' Curtis said.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Euronews
18 hours ago
- Euronews
Taliban deny British couple held in Afghan prison are being mistreated
The Taliban said on Wednesday that efforts to free a British couple from an Afghan prison are under way and denied that their rights are being violated, despite concerns from their relatives and UN officials. Peter and Barbie Reynolds, who are in their 70s, were arrested in early February after being taken from their home in central Bamiyan province to the capital, Kabul. The couple run an organisation that provides education and training programmes. Family members in the UK have said they are being mistreated and held on undisclosed charges. UN rights experts on Monday called for the pair's release, warning that their health was deteriorating rapidly and that they were at risk of irreparable harm or even death. The Taliban's Foreign Minister Amir Khan Muttaqi rejected concerns about rights violations. "They are in constant contact with their families," Muttaqi told reporters at a media briefing in Kabul on Wednesday. "Consular services are available. Efforts are underway to secure their release. These steps have not yet been completed. Their human rights are being respected. They are being given full access to treatment, contact and accommodation," he added. But Muttaqi did not outline what steps were being taken to secure the couple's release. According to the UN experts, the Reynolds' spell in detention included time in a maximum-security facility and later in underground cells before being moved to above-ground cells at the General Directorate of Intelligence in Kabul. Peter needs heart medication and, during his detention, suffered two eye infections as well as intermittent tremors in his head and down his left arm. He recently collapsed, the UN statement said, while Barbie suffers from anaemia and remains weak. "It is inhumane to keep them locked up in such degrading conditions and more worrying when their health is so fragile," said the UN experts, who called for their immediate transfer to a civilian hospital. The couple's adult children said in a statement on Sunday that Peter and Barbie have no bed or furniture and sleep on a mattress on the floor. Peter's face is red, peeling and bleeding, likely due to the return of skin cancer that urgently needs removing, they said. "We, their four adult children, have written privately to the Taliban leadership twice, pleading for them to uphold their beliefs of compassion, mercy, fairness, and human dignity," the children said. Officials from the UK Foreign Office (FCDO) visited the couple last week, the family said. "We are supporting the family of two British nationals who are detained in Afghanistan," an FCDO spokesperson said.


Local France
a day ago
- Local France
Why has the UK banned imports of French and Italian cheeses?
Bad news for UK residents who like iconic French cheeses such as artisan-produced brie, roquefort and reblochon or Italian classics such as pecorino ... these will no longer be available after the UK banned their imports from France or Italy. However if you are in those countries - or any other EU country - you can enjoy them to your heart's content. So what's going on? The UK's agriculture ministry Defra says that all imports of cheeses made in France or Italy with unpasturised milk are now banned. This affects any cheese made with raw milk or unpasturised milk - including some of France's most famous cheeses such as Vacherin, Roquefort, Mimolette and Tomme. Brie made by small artisan producers is likely to be unpasturised, although factory-produced brie can be made with pasturised milk. Advertisement It affects fewer Italian cheeses as the big names such as Parmesan are made with pasturised milk, but artisan-produced mozzarella is often made with raw milk, as is pecorino. You can find a full list of the affected cheeses here . Any cheeses produced before May 23rd are exempt, if the importer can produce the necessary paperwork - meaning that shortages will become apparent gradually, as some aged cheeses will continue to be imported over the next few months. The rules mostly affect commercial imports, but theoretically also apply to holidaymakers wanting to bring back a wheel of lovely, stinky European cheese. All of the above cheeses remain on sale throughout the EU. So why the UK ban? It's due to an outbreak of a cattle disease with the imaginative name of Lumpy Skin Disease (LSD) which, you will be surprised to hear, causes lumps on the skin of affected cattle. In France the disease is known as dermatose nodulaire contagieuse (DNC). It is spread by the bites of flies and mosquitoes. Italy confirmed its first case in Sardinia on June 21st, 2025, leading the UK to revoke Italy's LSD-free status and suspend unpasturised imports. France reported its first LSD case near Chambéry on June 29th. Quarantine zones are in place in the affected areas with a vaccination programme for the cattle, but cheese sales have not been suspended. The UK's import ban also affects the import of live cattle. Can Lumpy Skin Disease be spread by eating cheese? No, there is no risk to humans from eating cheese that has been produced by a cow suffering from LSD, and in fact humans cannot get LSD under any circumstances. The UK government says that it is acting to prevent the spread of the virus among British cattle - hence the ban on live cattle imports. It says that the virus can survive in raw milk, including cheese made with raw milk. So if a British cow ate a brie sandwich then it could get Lumpy Skin Disease. That sounds like a small risk? Frustrated cheese sellers in the UK say that the ban is disproportionate. Cheese-mongers told The Grocer magazine that the ban is "costly, illogical and deeply frustrating", saying there is no risk to people from these cheeses. Advertisement Shane Holland, a cheese retailer based in London, told UK newspaper The Independent : "The bigger question is, what is the ban for? "We completely understand restricting the movement of live cattle. LSD is an infectious disease from cattle to cattle. But if we're talking about from cattle to milk, there's no cattle-to-human transmission at all. Even if there was the tiniest risk, it's not being consumed by cattle anyway." A Defra spokesperson stood by the ban, saying: 'This government will do whatever it takes to protect British farmers and their herds from disease,' adding that most Italian cheeses, such as Parmesan, Mozzarella and Gorgonzola, should be unaffected as they are largely pasteurised. However the UK is not the only country to impose a ban - Canada has also banned imports of unpasturised cheese from France, Italy and Switzerland. Advertisement Is this why Eurostar is telling me I can't take a ham sandwich on my journey from Paris to London? No, that's a different issue, it's because of an outbreak of foot and mouth disease in continental Europe. Germany detected an outbreak in January but has since been declared FMD-free, however subsequent outbreaks in Hungary and Slovakia have persisted. In response, the UK recently announced that it has banned imports of meat or dairy products from European countries where the virus has been detected, as well as Austria due to the outbreak in neighbouring Hungary. However travellers are being advised that meat and dairy products from all EU countries are banned, which is why you may have received an email from Eurostar or ferry companies if you have recently travelled from France to the UK. Foot and mouth disease does not affect humans but is highly contagious among cattle. A major outbreak in the UK in 2001 led to the culling of more than six million animals and cost the economy billions, devastating the livestock industry and tourism.


Euronews
2 days ago
- Euronews
AstraZeneca pledges $50bn investment in the US amid 200% tariff fears
AstraZeneca will invest $50 billion (€42.8 bn) in the US by 2030 in a move to expand its R&D and manufacturing there, the firm announced on Monday. This comes as the pharmaceutical giant aims to reach the target of $80 billion (€68.5 bn) in revenue by 2030, with 50% of it hoped to come from the US. The announcement also comes as the Trump administration threatens tariffs of up to 200% on drugs that are produced outside of the US. The new investment announcement is in addition to the $3.5 billion (€3 bn) pledged in November 2024. According to a statement from the company, the US plays a 'critical role' in AstraZeneca's ability 'to launch 20 new medicines by the end of the decade'. What will AstraZeneca produce in the US? As part of the investment, the British-Swedish company plans to build a new multi-billion dollar manufacturing facility in the state of Virginia. This plant will focus on the production of treatments for chronic diseases and is the largest single investment into a facility the company has ever made. '[This] announcement underpins our belief in America's innovation in biopharmaceuticals and our commitment to the millions of patients who need our medicines in America and globally,' Pascal Soriot, Chief Executive Officer at AstraZeneca said in a statement from the company. 'I look forward to partnering with Governor Youngkin and his team to work on our largest single manufacturing investment ever. It reflects the Commonwealth of Virginia's desire to create highly skilled jobs in science and technology, and will strengthen the country's domestic supply chain for medicines.' The site in Virginia will have a particular focus on producing substances which make up AstraZeneca's weight management and metabolic treatment portfolio. As well as the site in Virginia, the investment will help expand facilities and production in Massachusetts, Maryland, California, Indiana and Texas, as well as finding new sites for clinical trials. AstraZeneca already has 19 R&D, manufacturing and commercial sites in the US, and the country is the company's largest market, representing 42% of their revenue. The firm currently employs more than 18,000 people and supports 92,000 jobs across the US. The new investment announcement is expected to create tens of thousands more jobs in the coming years. Howard Lutnick, US Secretary of Commerce, said: 'For decades Americans have been reliant on foreign supply of key pharmaceutical products. President Trump and our nation's new tariff policies are focused on ending this structural weakness. We are proud that AstraZeneca has made the decision to bring substantial pharmaceutical production to our shores. This historic investment is bringing tens of thousands of jobs to the US and will ensure medicine sold in our country is produced right here.'